Supplementary Table II (online only).
Hazard ratio | 95% CI | P-value | |
---|---|---|---|
COVID-19 infection | 6.2 | 2.3-16.8 | <.001 |
Age | 1.1 | 1.0-1.1 | .006 |
Gendera | 0.6 | 0.2-1.5 | .268 |
History of vascular interventionb | |||
Endoscopic | 0.4 | 0.11-1.5 | .168 |
Open | 1.4 | 0.4-5.4 | .63 |
Rutherford classificationc | |||
Class IIa | 2.7 | 0.7-10.8 | .156 |
Class IIb | 2.8 | 0.7-11.7 | .158 |
Class III | 3.6 | 0.5-23.9 | .186 |
Treatment typed | |||
Endovascular | 0.3 | 0.1-1.7 | .179 |
Hybrid | 1.3 | 0.4-4.1 | .591 |
Medical only | 0.9 | 0.2-4.1 | .984 |
Amputation | 4.5 | 0.5-42.9 | .196 |
CI, Confidence interval; COVID-19, coronavirus 2019.
Male gender is the reference group.
No history of vascular interventions is the reference group.
Rutherford Class I is the reference group.
Open surgical treatment is the reference group.